Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Dacarbazine × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 8 Melanoma 3 Uveal Melanoma 2 Lymphoma 2 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Melanoma, Cutaneous Malignant 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leiomyosarcoma 1 Immunotherapy 1 Advanced Melanoma 1

Interventions

Cyclophosphamide 5 Prednisone 4 Vincristine 3 Doxorubicin 3 Biopsy 3 Azacitidine 3 romidepsin 2 Gemcitabine 2 Dexamethasone 2 tazemetostat 1 sodium-iodide symporter 1 sintilimab 1 selinexor 1 ruxolitinib 1 relatlimab 1 pembrolizumab 1 ivarmacitinib 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cc-486 1 belinostat 1 X-Rays 1 Watchful Waiting 1 Spinal Puncture 1 Specimen Handling 1 Salvage Therapy 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡